IMMUNOPRECISE ANTIBOD.IMMUNOPRECISE ANTIBOD.IMMUNOPRECISE ANTIBOD.

IMMUNOPRECISE ANTIBOD.

No trades
See on Supercharts

TQB fundamentals

An in-depth look to IMMUNOPRECISE ANTIBOD. operating, investing, and financing activities

TQB free cash flow for Q3 23 is -346.49 k EUR. For 2022, TQB free cash flow was -14.56 M EUR and operating cash flow was -13.54 M EUR.

Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
‪0.00‬
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
TTM
Free cash flowYoY growth